BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5525313)

  • 1. Studies on the antitumor activity of 6-mercaptopurine riboside. II.
    Nakai Y; Sato K; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):99-105. PubMed ID: 5525313
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the antitumor activity of 6-merceptopurine riboside. I.
    Sato K; Nakai Y; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):92-8. PubMed ID: 5525312
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
    Kimball AP; LePage GA; Allinson PS
    Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

  • 5. [A method of primary selection of antitumor agents].
    Karaivanova MKh
    Vopr Onkol; 1971; 17(2):62-6. PubMed ID: 5567711
    [No Abstract]   [Full Text] [Related]  

  • 6. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905
    [No Abstract]   [Full Text] [Related]  

  • 8. The correlation between the antitumor activities and chemical structures of thiocyanato derivatives of purines and their ribonucleosides.
    Saneyoshi M; Tokuzen R; Maeda M; Fukuoka F
    Chem Pharm Bull (Tokyo); 1968 Mar; 16(3):505-8. PubMed ID: 5677940
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth of transplantable tumours in animals during combined treatment with cytostatics and yeast cell wall polysaccharide zymosan.
    Pfordte K; Ponsold W
    Neoplasma; 1971; 18(2):173-7. PubMed ID: 5577315
    [No Abstract]   [Full Text] [Related]  

  • 10. Disposition and metabolism of thiopurines. II. Arabinosyl-6-mercaptopurine and ribosyl-6-mercaptopurine.
    Loo TL; Lu K; Gottlieb JA
    Drug Metab Dispos; 1973; 1(4):645-52. PubMed ID: 4149639
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of action of 6-mercaptopurine and thioinosine, and clinical effects of the agents].
    Nakamura T
    Naika Hokan; 1970 Oct; 17(10):375-84. PubMed ID: 5529422
    [No Abstract]   [Full Text] [Related]  

  • 12. Formal discussion: future prospects in leukemia chemotherapy.
    Modest EJ
    Cancer Res; 1965 Oct; 25(9):1649-51. PubMed ID: 4221941
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthetic nucleosides and nucleotides. XIV. Facile synthesis and antitumor activities of 6-mercaptopurine 2'-deoxyriboside and related compounds.
    Saneyoshi M; Nishimura S; Okabe M; Fukuoka F
    J Pharmacobiodyn; 1980 Feb; 3(2):105-10. PubMed ID: 6162940
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy: treatment of the Ehrlich ascites carcinoma and several drug-resistant sublines with combinations of 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Can J Biochem; 1970 Jan; 48(1):79-83. PubMed ID: 5512546
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models.
    Tumminello FM; Leto G; Gebbia N; Rausa L; Bernacki RJ
    J Chemother; 1989 Jul; 1(4 Suppl):1135-8. PubMed ID: 16315374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect, on kidney structure, of the use of antitumor preparations combined with diacarb and furosemide].
    Aref'eva AK; Rykov VA
    Farmakol Toksikol; 1982; 45(5):78-80. PubMed ID: 6890469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineoplastic and immunodepressive activity of purinylglutathionyl disulfide].
    Sokolov AV; Syrkin AB; Fontalin LN; Pevnitskiĭ LA; Solov'ev VV
    Farmakol Toksikol; 1972 Jul; 35(4):473-7. PubMed ID: 5050282
    [No Abstract]   [Full Text] [Related]  

  • 18. Search for antitumor compounds. XIII. Biological studies. Antitumor properties of 20 quinolines, carbazoles, acridines nitro derivatives.
    Hrabowska M; Ledóchowski A; Wysocka-Skrzela B; Onoszko K; Paradziej-Lukowicz J
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):205-16. PubMed ID: 7305632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the effect of a new verucarin E analog WER I on the growth of experimental neoplasms].
    Nowak HF; Jodczyk KJ; Zimnoch L; Duda D; Piotrowska-Olczak H; Rózański A
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1980; 25():175-95. PubMed ID: 6797024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.